Tag: BetterLife Pharma - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article BetterLife Pharma to Host Investors Update Call on September 18, 2023

BetterLife Pharma to Host Investors Update Call on September 18, 2023

Post published:September 14, 2023
Post category:Press Release

Read more about the article BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001

BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001

Post published:September 12, 2023
Post category:Press Release

Read more about the article BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement

BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement

Post published:September 5, 2023
Post category:Press Release

Read more about the article BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement

BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement

Post published:July 13, 2023
Post category:Press Release

Read more about the article BetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD Derivatives

BetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD Derivatives

Post published:June 27, 2023
Post category:Press Release

Read more about the article BetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, Canada

BetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, Canada

Post published:June 22, 2023
Post category:Press Release

Read more about the article BetterLife Continues Progress on BETR-001 IND-Enabling Studies

BetterLife Continues Progress on BETR-001 IND-Enabling Studies

Post published:June 8, 2023
Post category:Press Release

Read more about the article BetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, California

BetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, California

Post published:April 25, 2023
Post category:Press Release

Read more about the article BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

Post published:April 20, 2023
Post category:Press Release

Read more about the article BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article

BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article

Post published:March 29, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.